
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. (RXDX) Number of Employees – History & Annual Headcount
Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.
SEC EDGAR · FMP · RXDX · as of Feb 28, 2023
Latest filing snapshot
Prometheus Biosciences, Inc. (RXDX) employee data is sourced from the annual SEC 10-K filing. As of 2022, full-time employees only. Global consolidated headcount. View SEC filing ↗
RXDX Employee Count
2021 – 2022 · Annual · SEC filingSource: SEC annual filings · Hover bar to view year data · Click to view original filing
Employees History
▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.
Related Companies — Employee Count
BiotechnologyAbout RXDX employees
RXDX Employees · Headcount
Prometheus Biosciences, Inc. (RXDX) employee data is sourced from the annual SEC 10-K filing. As of 2022, Prometheus Biosciences, Inc. had 97 full-time employees globally. Full-time employees only. Global consolidated headcount.
Prometheus Biosciences, Inc. employs 97 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $70,196, reflecting the company's operational efficiency.
Prometheus Biosciences, Inc.'s workforce increased by 25 (34.72%) in 2022 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.
Prometheus Biosciences, Inc.'s revenue per employee of $70,196 positions it among the notable performers in the Biotechnology sector for operational efficiency.
Frequently Asked Questions
RXDX Employees · 5 questionsAs of the latest SEC 10-K filing (2022), Prometheus Biosciences, Inc. had 97 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.
▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2023-02-28